Get the Stockscreener App
66.09
0.47%
-0.31
After Hours:
66.18
0.09
+0.14%
State Street Spdr S P Pharmaceuticals Etf stock is traded at $66.09, with a volume of 65,497.
It is down -0.47% in the last 24 hours and down -10.17% over the past month.
See More
Previous Close:
$66.40
Open:
$66.6
24h Volume:
65,497
Relative Volume:
0.48
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.27%
1M Performance:
-10.17%
6M Performance:
+22.89%
1Y Performance:
+44.24%
1-Day Range:
$65.70
$66.69
1-Week Range:
$65.50
$68.96
52-Week Range:
$46.24
$74.34
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
66.09 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
379.77 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
771.35 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
774.83 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
289.70 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
744.50 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
iShares U.S. Pharmaceuticals ETF (IHE) stock price, news, quote and history - au.finance.yahoo.com
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Best Performing ETFs: Top Returns at a Glance - TradingKey
State Street SPDR S&P Insurance ETF (KIE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Eastern Progress
ETFs Investing in Corcept Therapeutics Incorporated. Stocks - TradingView
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Health Care Services ETF (XHS) a Strong ETF Right Now? - Yahoo Finance
ETFs Investing in Ligand Pharmaceuticals Incorporated Stocks - tradingview.com
Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)? - Yahoo Finance
Comparing Healthcare ETFs: Broad vs. Focused Exposure - Intellectia AI
IXJ vs XPH: Global Healthcare ETF or Pharma Focus? - fool.com
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView
Broad Coverage or Concentrated Bets? Analyzing the Differences Between Healthcare Funds VHT and XPH - NAI500
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - fool.com
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - The Motley Fool
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? - fool.com
ETFs Investing in ANI Pharmaceuticals, Inc. Stocks - TradingView
Ditch These Historic ETF September Underperformers - Finviz
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) rated B... - Pluang
XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI) - Seeking Alpha
Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense - Barron's
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
State Street SPDR S&P/ASX 200 Listed Property ETF Reports Daily NAV Update for September 2, 2026 - Kalkine Media
State Street SPDR S&P/ASX 200 ETF Announces Daily NAV and Fund Update for September 1, 2026 - Kalkine Media
Should You Invest in the State Street SPDR S&P Homebuilders ETF (XHB)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Eastern Progress
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - AOL.com
Healthcare ETFs Are Looking Up: Here's Why - cnhinews.com
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
XPH vs PJP: Which Pharma ETF Offers Better Value - The Motley Fool
ETFs Investing in Arrowhead Pharmaceuticals, Inc. Stocks - TradingView
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Biotechnology vs. Pharmaceuticals: What Are the Differences? - The Motley Fool
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH - The Motley Fool
ETFs Investing in Viatris, Inc. Stocks - TradingView
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
8 ETF Winners in the ‘Pay Me Now’ Trade - Barron's
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):